A cytotoxic human-human hybridoma antibody (TrC7) specific for HLA-A29
- 1 May 1989
- journal article
- research article
- Published by Wiley in Tissue Antigens
- Vol. 33 (5) , 542-545
- https://doi.org/10.1111/j.1399-0039.1989.tb01705.x
Abstract
TrC7 is a cytotoxic IgM human-human hybridoma anti-HLA Ab*. Its reaction pattern with a panel of 48 HLA-typed EBV*-transformed cell lines and PBMC* from 348 HLA-typed individuals correlated precisely with expression of HLA-A29. TrC7 did not react with HLA-A30, -31, -32 or -w33, which, like A29, are splits of Aw19.This publication has 20 references indexed in Scilit:
- Nomenclature for Factors of the HLA System, 19871Vox Sanguinis, 1988
- A human-human hybridoma antibody (TrB12) defining subgroups of HLA-DQw1 and -DQw3Human Immunology, 1987
- Simple rosette assay for HLA‐B27 typing of whole blood samplesTissue Antigens, 1987
- A human‐human hybridoma producing cytotoxic antibody to HLA‐B15, cross‐reacting with B17, B5, B35 and B18Tissue Antigens, 1987
- HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation ‐ a fast and reliable techniqueTissue Antigens, 1986
- In vitro production of a human HLA alloantibody of restricted specificity (DQw2) via Epstein-Barr virus transformationHuman Immunology, 1986
- Treatment of (NZB x NZW)F1 disease with anti-I-A monoclonal antibodies.The Journal of Experimental Medicine, 1983
- Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysisCell, 1978
- Standardization of the HLA Typing Method and ReagentsVox Sanguinis, 1978
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975